PharmaMar to participate at the 23rd Annual Needham Virtual Healthcare Conference

On April 8, 2024 PharmaMar (MSE:PHM), world leader in the research, development and commercialization of marine-derived anticancer drugs, reported that the Company will participate in the 23rd Annual Needham Virtual Healthcare Conference taking place virtually on April 8-11, 2024 (Press release, PharmaMar, APR 8, 2024, View Source [SID1234641876]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

PharmaMar’s management team, will meet with institutional investors, private equity and venture capital investors, and participate in a fireside chat with Needham’s Research Analyst on April 9th at 08:45 Eastern (14:45 CET).

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!